iCureASPS Fundraising

Summer 2022: Updated Clinical Research on Alveolar Soft Part Sarcoma

Related ASPS News

New Therapeutic Targets in Alveolar Soft Part Sarcoma were revealed in a new study conducted...

On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.)...